Treatment With Lorcaserin for Cocaine Use: The TLC Study
Status:
Terminated
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This project is a placebo-controlled, double-blind randomized trial evaluating the
feasibility, tolerability, acceptability and adherence for lorcaserin among actively using,
men who have sex with men (MSM) with cocaine use disorders.The study will enroll 45
individuals who will randomly be assigned to either the treatment (lorcaserin) arm or the
placebo arm, to be taken twice a day for 12 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Glenn-Milo Santos University of California, San Francisco